Leadiant Biosciences is managed by a team of executives with exceptional experience in the all different aspects of the pharmaceutical business, with special expertise in the development, registration and commercialization of rare disease products.
Dr. Gama da Silva is the Chief Executive Officer at Leadiant Biosciences, Ltd., where he is responsible for managing the group’s international business (ex-USA and Canada). Dr. Gama da Silva brings more than 20 years of experience in the pharmaceutical industry having held different positions of increasing responsibility at global companies such as Novartis, AstraZeneca, FAES Group, Bayer and Octapharma.
Dr. Gama da Silva received his M.D. from Lisbon University Medical School. He is a consultant in Allergology and Clinical Immunology.
Dr. Verma is the Chief Medical Officer at Leadiant Biosciences Ltd. She was appointed CMO in 2016 after serving two years as Medical Director. Prior to joining the company Dr. Verma held several positions in a wide range of therapeutic areas. She spent more than 12 years in clinical practice in The National Health Service (NHS), specialising in Maxillofacial Surgery.
Dr. Verma received her M.D. at the University of London, with a Master’s in Surgical Technology from Imperial College. She is also qualified as a dental surgeon, and holds a Fellowship from the Royal College of Surgeons, England.
Dr. Adejuyigbe is Head of Regulatory Affairs and Quality Assurance at Leadiant Biosciences Ltd. She is responsible for the overall regulatory strategy and operations, from development through post- marketing in Europe and the rest of the world, to management of the overall quality system. Dr. Adejuyigbe joined the company in 2013 as manager of regulatory affairs and quality assurance.
Prior to joining Leadiant Biosciences Ltd., Dr. Adejuyigbe worked for several years at the Medicines and Healthcare products Regulatory Agency (MHRA) in London as a pharmaceutical assessor, and then moved on to senior roles in the regulatory affairs department at GlaxoSmithKline in London and Genzyme in the Netherlands.
Dr. Adejuyigbe is a registered pharmacist and earned her doctorate degree in pharmacy from Kings College London, UK where she specialised in the development of multi-mode optical spectroscopy of proteins and peptides.
Mr. Teixeira da Silva is Head of International Marketing and Market Access at Leadiant Biosciences Ltd. He is responsible for the overall market access and marketing strategy as well as commercial operations from development through post-marketing in Europe and the rest of the world.
Mr. Teixeira da Silva joined the company in 2014 as Head of Marketing with the responsibility to prepare the company to commercialize its new products.
Prior to joining Leadiant Biosciences Ltd., Mr. Teixeira da Silva worked for several years at Bayer Pharmaceuticals in the USA as a Global Brand manager, as well as several other regional marketing and country roles within Bayer, Astellas and AstraZeneca. His background includes experience in several therapeutic areas including Oncology, Transplantation, CNS and Respiratory.
Mr. Teixeira da Silva is a biologist and earned degree in biology from Universidade de Evora, Portugal and a Master’s degree in Marketing from Instituto Superior de Economica e Gestao (ISEG) in Portugal.
